India, Australia partner to develop vaccine for COVID-19

Indian Immunologicals Limited (IIL), a leading vaccines manufacturing company, has announced that the company is going t...

April 8, 2020 | Wednesday | News
CSIRO begins testing COVID-19 vaccines

The Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia’s national science agency, has...

April 2, 2020 | Thursday | News
Medicago announces production of viable vaccine candidate for COVID-19

Medicago, a biopharmaceutical company headquartered in Quebec City, Canada has announced that they have successfully pro...

March 27, 2020 | Friday | News
Novavax, Serum Institute of India to co-develop malaria Vaccine

Novavax and Serum Institute of India (SII) has announced a commercial license agreement for the use of Novavax’ pr...

March 17, 2020 | Tuesday | News
CEPI expands investment in COVID-19 vaccine development

CEPI, the Coalition for Epidemic Preparedness Innovations, on 10 March 2020 announced the expansion of its COVID-19 vacc...

March 11, 2020 | Wednesday | News
SII expects human trials for COVID-19 vaccine in 6 months

Serum Institute of India Pvt. Ltd. (SIIPL), the world's largest vaccine manufacturer by number of doses produced and sol...

February 20, 2020 | Thursday | News
NUS works on COVID-19 vaccine trial and rapid test kits

Scientists from the National University of Singapore (NUS) community are working on a vaccine trial and rapid detection ...

February 19, 2020 | Wednesday | News
WuXi Vaccines to build integrated manufacturing facility

WuXi Vaccines, a new vaccine Contract Development and Manufacturing Organization (CDMO) established between WuXi Biologi...

February 18, 2020 | Tuesday | News
Pfizer Vaccines launches global centers of excellence network

Pfizer Inc. has announced the launch of its Vaccines Division’s Centers of Excellence Network, a global program of...

January 24, 2020 | Friday | News
Sinovac receives China's approval for varicella vaccine

Sinovac Biotech, a leading provider of biopharmaceutical products in China, has announced that the China National Medica...

December 31, 2019 | Tuesday | News
Merck gets FDA nod for Ebola vaccine

The U.S. Food and Drug Administration has announced the approval of Ervebo, the first FDA-approved vaccine for the preve...

December 23, 2019 | Monday | News
Vaccitech provides update for its Phase 2 Universal Influenza studies

Vaccitech Ltd, a clinical-stage T cell immunotherapy company developing products to treat and prevent cancer and infecti...

November 25, 2019 | Monday | News
NEC, VAXIMM to advance personalized neoantigen cancer vaccines

Japan based NEC Corporation, a leader in IT and network technologies, and VAXIMM AG, a Swiss/German biotech company focu...

November 15, 2019 | Friday | News
Takeda’s Dengue vaccine candidate reveals protection in children

Japan based Takeda Pharmaceutical Company Limited has announced that results from the primary endpoint analysis of ...

November 8, 2019 | Friday | News
FDA approves Sanofi’s Influenza Vaccine for older people

The U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application for Fluzone®&n...

November 5, 2019 | Tuesday | News
The Union reports efficacy of its TB Vaccine Candidate

International Union Against Tuberculosis and Lung Disease (The Union) headquartered in France, announces the Phase IIb T...

October 30, 2019 | Wednesday | News
NIH awards contracts to advance tuberculosis immunology research

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarde...

September 27, 2019 | Friday | News
Alwaleed Philanthropies invests $5 M in global fight for vaccines

Alwaleed Philanthropies, chaired by HRH Prince Alwaleed Bin Talal Bin Abdulaziz AlSaud, the global philanthropic fo...

September 2, 2019 | Monday | News